Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jul 2020
Historique:
received: 29 05 2020
revised: 01 07 2020
accepted: 07 07 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 3 3 2021
Statut: epublish

Résumé

Extracellular vesicles (EVs) play key roles in glioblastoma (GBM; astrocytoma grade IV) biology and are novel sources of biomarkers. EVs released from GBM tumors can cross the blood-brain-barrier into the periphery carrying GBM molecules, including small non-coding RNA (sncRNA). Biomarkers cargoed in circulating EVs have shown great promise for assessing the molecular state of brain tumors in situ. Neurosurgical aspirate fluids captured during tumor resections are a rich source of GBM-EVs isolated directly from tumor microenvironments. Using density gradient ultracentrifugation, EVs were purified from cavitron ultrasonic surgical aspirate (CUSA) washings from GBM (

Identifiants

pubmed: 32668808
pii: ijms21144954
doi: 10.3390/ijms21144954
pmc: PMC7404297
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
MIRN486 microRNA, human 0
MicroRNAs 0
RNA, Neoplasm 0
RNA, Small Interfering 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nanomedicine. 2011 Dec;7(6):780-8
pubmed: 21601655
J Cell Biochem. 2012 Feb;113(2):373-80
pubmed: 21928326
Bull Exp Biol Med. 2016 May;161(1):112-5
pubmed: 27265126
Genes Dev. 2006 Jul 1;20(13):1732-43
pubmed: 16766679
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Neuro Oncol. 2018 Oct 9;20(11):1505-1516
pubmed: 29846705
Int J Clin Exp Med. 2015 Jun 15;8(6):9114-20
pubmed: 26309566
Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162
pubmed: 30423142
BMC Cancer. 2012 Jan 17;12:22
pubmed: 22251860
Int J Med Sci. 2018 Jan 1;15(2):142-152
pubmed: 29333098
J Neurooncol. 2017 Oct;135(1):37-46
pubmed: 28948499
Proteomics. 2013 Nov;13(22):3354-64
pubmed: 24115447
Pancreas. 2009 Oct;38(7):e190-9
pubmed: 19730150
Cell Res. 2013 Feb;23(2):274-89
pubmed: 23247627
Curr Oncol Rep. 2010 Jan;12(1):26-33
pubmed: 20425605
PLoS One. 2013 Oct 21;8(10):e78115
pubmed: 24205116
Biomark Cancer. 2017 Jan 09;9:1-8
pubmed: 28096697
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Oncotarget. 2017 Jul 27;8(36):60704-60709
pubmed: 28948004
Sci Rep. 2018 Jul 17;8(1):10813
pubmed: 30018314
Biochemistry (Mosc). 2013 Mar;78(3):221-30
pubmed: 23586714
Onco Targets Ther. 2015 Dec 31;9:139-48
pubmed: 26770063
Clin Chim Acta. 2011 Aug 17;412(17-18):1621-5
pubmed: 21616063
J Biol Chem. 2014 Sep 5;289(36):25079-87
pubmed: 25059666
Mol Cell Pharmacol. 2011;3(3):83-92
pubmed: 22468167
Science. 1997 Mar 28;275(5308):1943-7
pubmed: 9072974
Cell Physiol Biochem. 2017;44(1):1-20
pubmed: 29130960
Mod Pathol. 2010 Oct;23(10):1404-17
pubmed: 20711171
Biomedicines. 2017 Jun 09;5(2):
pubmed: 28598356
Brain Tumor Pathol. 2019 Apr;36(2):29-39
pubmed: 30859343
Am J Cancer Res. 2017 May 01;7(5):1136-1150
pubmed: 28560062
J Neurooncol. 2018 Jan;136(1):51-62
pubmed: 29076001
Oncol Lett. 2017 Aug;14(2):2141-2146
pubmed: 28781655
BMC Genomics. 2013 May 10;14:319
pubmed: 23663360
Theranostics. 2018 Feb 7;8(6):1540-1557
pubmed: 29556340
Nat Commun. 2016 Mar 29;7:11150
pubmed: 27021436
PLoS One. 2019 Jan 4;14(1):e0210003
pubmed: 30608951
Clin Cancer Res. 2013 Feb 15;19(4):764-72
pubmed: 23209033
Oncotarget. 2018 Dec 28;9(102):37616-37626
pubmed: 30701019
Cancer Res. 2010 Oct 15;70(20):8108-16
pubmed: 20813833
Oncotarget. 2016 Aug 16;7(33):53853-53868
pubmed: 27462780
RNA Biol. 2015;12(8):810-23
pubmed: 26176991
Oncotarget. 2016 Jun 21;7(25):37944-37956
pubmed: 27177224
Oncotarget. 2015 Mar 10;6(7):4677-91
pubmed: 25686835
Cancer Res. 2017 Nov 1;77(21):5808-5819
pubmed: 28855213
Semin Cancer Biol. 2014 Oct;28:14-23
pubmed: 24783980
Int J Oncol. 2016 Jun;48(6):2567-79
pubmed: 27035745
Proteomics. 2019 Jan;19(1-2):e1800157
pubmed: 30451371
Clin Chim Acta. 2010 Jun 3;411(11-12):846-52
pubmed: 20223231
Cancer Manag Res. 2019 Apr 29;11:3703-3720
pubmed: 31118791
Hepatology. 2011 Oct;54(4):1237-48
pubmed: 21721029
Cancer Manag Res. 2019 Jun 28;11:5895-5909
pubmed: 31303794
J Extracell Vesicles. 2013 Sep 12;2:
pubmed: 24223256
Oncol Rep. 2012 Apr;27(4):1019-26
pubmed: 22267008
Mol Ther Nucleic Acids. 2013 Jul 23;2:e109
pubmed: 23881452
Cell Cycle. 2010 Jul 15;9(14):2742-8
pubmed: 20647762
Oncotarget. 2015 Sep 29;6(29):26971-81
pubmed: 26284486
RNA Biol. 2018;15(8):1133-1145
pubmed: 30223713
Int J Cancer. 1999 Jul 2;82(1):12-6
pubmed: 10360813
PLoS One. 2013 Jun 18;8(6):e66165
pubmed: 23824282
Neuromolecular Med. 2020 Sep;22(3):359-369
pubmed: 32086739
Oncotarget. 2017 Jun 1;8(40):68769-68779
pubmed: 28978155
Sci Rep. 2015 May 27;5:10423
pubmed: 26013764
Mol Med. 2015 May 13;21:381-8
pubmed: 25998508
J Mol Cell Biol. 2014 Jun;6(3):206-13
pubmed: 24740682
Int J Biochem Cell Biol. 2016 Apr;73:72-81
pubmed: 26860959
J Extracell Vesicles. 2018 Jun 04;7(1):1481321
pubmed: 29887978
Methods Mol Biol. 2018;1740:1-15
pubmed: 29388131
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33
pubmed: 20304794
Virology. 2017 Aug;508:63-69
pubmed: 28500882
J Neurooncol. 2017 Jan;131(2):233-244
pubmed: 27770278
Cell. 2007 Jun 29;129(7):1401-14
pubmed: 17604727
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Onco Targets Ther. 2019 Apr 29;12:3181-3196
pubmed: 31118671
Clin Transl Oncol. 2013 Jul;15(7):563-8
pubmed: 23229900
NPJ Precis Oncol. 2018 Dec 12;2:28
pubmed: 30564636
PLoS One. 2013;8(1):e53906
pubmed: 23372675
PLoS One. 2017 May 4;12(5):e0176680
pubmed: 28472171
Oncotarget. 2017 Sep 14;8(46):80666-80678
pubmed: 29113334
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Oncotarget. 2016 Mar 29;7(13):16923-35
pubmed: 26943577
Eur J Pharm Sci. 2017 Feb 15;98:70-79
pubmed: 27751843
J Neurooncol. 2015 Jun;123(2):205-16
pubmed: 25903655
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Cell Commun Signal. 2013 Nov 18;11:88
pubmed: 24245560
PLoS One. 2018 Jan 10;13(1):e0190485
pubmed: 29320577
Nat Cell Biol. 2008 May;10(5):619-24
pubmed: 18425114
Clin Cancer Res. 2009 Nov 15;15(22):6830-40
pubmed: 19861441
Oncol Rep. 2011 Oct;26(4):1011-7
pubmed: 21743970
Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8
pubmed: 27668386
Nucleic Acids Res. 2019 Jan 8;47(D1):D89-D93
pubmed: 30335161
RNA Biol. 2013 Aug;10(8):1333-44
pubmed: 23807490
Clin Epigenetics. 2017 Oct 17;9:114
pubmed: 29075357
Cancers (Basel). 2018 Sep 01;10(9):
pubmed: 30200436
Genes Dis. 2017 Dec 09;5(1):36-42
pubmed: 30258933
Brain Res. 2011 Feb 10;1373:183-8
pubmed: 21138738
Genes Dev. 2012 Nov 1;26(21):2361-73
pubmed: 23124062
Eur J Cancer. 2003 Jan;39(2):184-91
pubmed: 12509950
Cancer Med. 2017 Dec;6(12):2858-2866
pubmed: 29105360
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Pharm Res. 2015 Jun;32(6):2003-14
pubmed: 25609010
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4218-23
pubmed: 20142475

Auteurs

Susannah Hallal (S)

Department of Neurosurgical Services, Chris O'Brien Lifehouse, Camperdown 2050, Australia.
Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.
Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.
Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.

Saeideh Ebrahim Khani (S)

Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.

Heng Wei (H)

Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.
Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.

Maggie Yuk Ting Lee (MYT)

Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.
Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.

Hao-Wen Sim (HW)

Department of Medical Oncology and NHMRC Clinical Trials Centre, Chris O'Brien Lifehouse, Camperdown 2050, Australia.
Central Clinical School, The University of Sydney, Sydney 2006, Australia.
The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst 2010, Australia.

Joanne Sy (J)

Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.

Brindha Shivalingam (B)

Department of Neurosurgical Services, Chris O'Brien Lifehouse, Camperdown 2050, Australia.
Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.

Michael E Buckland (ME)

Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.
Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.
Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.

Kimberley L Alexander-Kaufman (KL)

Department of Neurosurgical Services, Chris O'Brien Lifehouse, Camperdown 2050, Australia.
Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.
Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.
Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH